1. Home
  2. NRC vs TECX Comparison

NRC vs TECX Comparison

Compare NRC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$22.30

Market Cap

504.8M

Sector

Health Care

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.86

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
TECX
Founded
1981
2019
Country
United States
United States
Employees
N/A
60
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.8M
549.5M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NRC
TECX
Price
$22.30
$30.86
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$75.20
AVG Volume (30 Days)
102.1K
184.8K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
3.86%
N/A
EPS Growth
4707.69
N/A
EPS
0.14
N/A
Revenue
$119,686,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$157.50
N/A
Revenue Growth
1.81
N/A
52 Week Low
$11.01
$14.39
52 Week High
$23.00
$39.53

Technical Indicators

Market Signals
Indicator
NRC
TECX
Relative Strength Index (RSI) 61.02 43.77
Support Level $16.74 $27.31
Resistance Level $22.90 $31.39
Average True Range (ATR) 0.96 2.72
MACD -0.05 -0.42
Stochastic Oscillator 68.71 4.57

Price Performance

Historical Comparison
NRC
TECX

About NRC National Research Corporation (Delaware)

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: